longevity – Learning with Lowell: Recent Episodes
Lowell Thompson
In this episode of the Learning with Lowell podcast, host Lowell Thompson welcomes Olivia Lesslar and Alexander Layendecker, two experts in the fields of space life sciences and medicine. The discussion delves into the challenges...Source
“My long-term goal is to model the pathways involved in human aging in order to develop therapeutic interventions. I organize an annual aging conference in the Midwestern United States with the dual goal of promoting...Source
Dr. Peter Lidsky posits that aging is not merely a process of accumulating damages, as commonly believed, but rather a programmed adaptation akin to a part of the immune system. His hypothesis suggests that aging...Source
“Dr. Admasu earned his PhD in Biochemistry from national university of Singapore. In his PhD work he investigated interactions between lifespan extending drugs with the aim of engineering synergistic benefits in C. elegans. Dr. Admasu...Source
Joined with Jeffrey D. Gross, MD, a spine fellowship trained, board certified neurological surgeon. In his practice, he provides specialized treatment options for patients with neck and/or back problems, as well as brain and head...Source
video interview Dive into the fascinating world of cryptocurrencies, biotech innovation, and space exploration with Dane and Lowell. From navigating the complexities of crypto investments to discussing groundbreaking aging research funded by organizations like the...Source
Matthew and Lowell discussed the development of a new DNA targeting intervention to clear senescent cells. They highlighted the unique approach of Oisin, which targets cells based on their transcriptional activity rather than their appearance...Source
Dr. Kelsey Moody is a process-oriented biotechnology executive who has specialized in the study of aging and aging mechanisms for over a decade. Since 2013, He has successfully built Ichor from a living room start-up...Source
Dr. Amit Sharma was awarded a Master’s degree in Biomedical Sciences from Delhi University, India. He received his PhD in 2009 in Biotechnology from University of Pune for his work demonstrating microRNA regulation of cytokines...Source
Danielle Ruiz is a highly accomplished professional with a background in nursing and a strong commitment to improving the healthcare system. As CEO and Medical Director of Everest Health Partners, she is dedicated to extending...Source
Jan Vijg, a foremost expert on DNA, aging, and the cutting edge of innovation. His lab at Albert Einstein College of Medicine studies the process of human aging, its causal mechanisms, and how these mechanisms... Source
newsletter https://learningwithlowell.us12.list-manage.com/subscribe?u=08ed8a56013d8b3a3c01e27fc&id=6ecaa9189b Advances in Longevity Research Economic and Funding Considerations Controversial Concepts in Longevity TLDR: The key idea of the video is that medical innovations and research in longevity can potentially postpone age-related illnesses and... Source
Join Jean Hebert, a leading expert in brain health, as he delves into the transformative potential of brain tissue replacement, brain computer interfaces, and their implications for reversing aging. In this comprehensive discussion, Jean shares... Source
Michael Rae is the author with Aubrey De Grey of “Ending Aging”, and “is the author of five scientific articles and commentaries in peer-reviewed scientific journals. Much of his work has been devoted to elucidating... Source
Javier Tordable is a technology executive, investor and entrepreneur. In his role as Technical Director at the CTO Office Javier drives long term technical strategy for Google Cloud. Join this channel to get access to... Source
Nir Barzilai is the founding director of the Institute for Aging Research, the Nathan Shock Center of Excellence in the Basic Biology of Aging and the Paul F. Glenn Center for the Biology of Human... Source
Andy Lee of Vincere Biosciences. “Our innovative pipeline consists of small molecules designed to boost mitophagy, with the potential to become the first-ever medicines capable of slowing or stopping Parkinson’s disease and other age-related conditions.”... Source
Nikhil Yadala Founder of Healome , fellow at On Deck, former engineer at Microsoft working on Bing, Maker of longevityGPT. ChatGPT is a text model, which LongevityGPT is built on top of. Over 321 books from 170 plus interviews over 5 years Newsletter sign up (new and exciting developments) https://learningwithlowell.us12.list-manage.com/subscribe?u=08ed8a56013d8b3a3c01e27fc&id=6ecaa9189b PODCAST INFO: The Learning With …
Nikhil Yadala – Unleashing LongevityGPT, Decoding OpenAI, ChatCPT, & LLMs- Learning with Lowell 190 Read More »
The post Nikhil Yadala – Unleashing LongevityGPT, Decoding OpenAI, ChatCPT, & LLMs- Learning with Lowell 190 first appeared on Learning with Lowell.
Dr. Matt Kaeberlein is the Chief Science Officer of Optispan. Previously, he was a Professor of Laboratory Medicine and Pathology at the University of Washington where he led several large research initiatives and centers focused on the biological mechanisms of aging. He is a fellow of the American Association for the Advancement of Science, the …
Matt Kaeberlein – Unlocking the Secrets of Rapamycin & Longevity – Learning with Lowell 187 Read More »
The post Matt Kaeberlein – Unlocking the Secrets of Rapamycin & Longevity – Learning with Lowell 187 first appeared on Learning with Lowell.
Collin Yvès Ewald is a Swiss scientist investigating the molecular mechanisms of healthy aging. He is a molecular biologist and a professor at ETH Zurich, where he leads the Laboratory of Extracellular Matrix Regeneration
The post Extracellular Matrix, Machine Learning, & Longevity Research Collin Ewald -Learning with Lowell 185 first appeared on Learning with Lowell.
Dr. Eric Leire is the CEO of Genflowbio, and is the the inventor of several medical patents. He also serves on the board of several biotechnology companies (Immunethep, BSIM, Inhatarget). Furthermore, Dr Eric has been CEO of several gene and cell therapy companies such as Enochian Biosciences (Nasdaq: ENOB) and DanDrit Biotechnologies (OTC.QB:DDRT). He holds …
Dr. Eric Leire – Gene Therapy, Reprogramming, Fasting, & Longevity – Learning with Lowell 183 Read More »
The post Dr. Eric Leire – Gene Therapy, Reprogramming, Fasting, & Longevity – Learning with Lowell 183 first appeared on Learning with Lowell.
Nikolina Lauc Co-Founder & CE0 GlycanAge, which seeks to Unlock the human glycome for preventative health and longevity. GlycanAge was founded on a promise that “health care” should start with us caring about our health before we encounter a particular problem. Over 321 books from 170 plus interviews over 5 years Newsletter sign up (new …
Understanding Glycome can Revolutionize your Longevity – Nikolina Lauc -Learning with Lowell 181 Read More »
The post Understanding Glycome can Revolutionize your Longevity – Nikolina Lauc -Learning with Lowell 181 first appeared on Learning with Lowell.
Dr. Björn Schumacher is the Principal Investigator and Chair for Genome Stability in Ageing and Disease at the Institute for Genome Stability in Aging and Disease. His research group uses the nematode worm Caenorhabditis elegans to understand the causal role of DNA damage in aging and disease.
The post Dr. Bjorn Schumacher – DNA Repair Mechanisms, Longevity, & DREAM complex – Learning with Lowell 180 first appeared on Learning with Lowell.
Michael Forrest is a Cambridge university biochemistry graduate. Ph.D. computer science. Founder CEO of Biophysical Therapeutics, which is focused on drugs and interventions to slow aging and promote longevity.
The post Missing Link between Metabolism, Longevity, & Healthspan -Michael Forrest – Learning with Lowell 177 first appeared on Learning with Lowell.
Doug Ethell is the founder and CEO of Leucadia Therapeutics, a pre-clinical stage company developing an early diagnostic for Alzheimer's disease and a therapeutic device to stop that disorder in its earliest stages.
The post A Cure for Alzheimer’s disease? – CEO of Leucadia Therapeutics Doug Ethell -Learning with Lowell 176 first appeared on Learning with Lowell.
Sebastian Brunemeier, Building Puerto Rico, Puerto Rico Money, ImmuneAGE Locations, Switzerland Benefits, Distributed Biotech, ChatGPT, vitaDAO, DAOs, Non-profit, Accredited Investors, Mental Energy, Ageism, Hopelessness, Downhill After 18, Psychometrics, Healthspan Capital, Mouse Bottleneck, Business Opportunity, Mouse Models, Synthetic Models, Age-related Diseases, Human vs Mice, Cloning, Reverse Yamanaka Factors, Progeria Cells, IP, Investing, Contracting Out, Matthew "Oki" O'Connor, Cyclarity, Cholesterol, Brain Aging, Bone Marrow Transplant, ImmuneAge Special Sauce, Competitors, Biobank, Missing Team Members, Books, Longevity Biotech Fellowship,
The post Bone Marrow Transplants & ImmuneAGE Special Sauce- Sebastian Brunemeier -Learning with Lowell 175 first appeared on Learning with Lowell.
Stephanie Dainow is the Executive Director at Lifespan.io / Lifespan Extension Advocacy Foundation a longevity non profit organization.
The post Building a Movement for Longevity – Stephanie Dainow – Learning with Lowell 173 first appeared on Learning with Lowell.
Jennifer Garrison is an assistant professor at the Buck Institute for Research on Aging and also holds appointments in the Department of Cellular and Molecular Pharmacology at University of California, San Francisco (UCSF) and the Davis School of Gerontology at the University of Southern California. Over 321 books from 170 plus interviews over 5 years … Dr. Jennifer Garrison: Reproductive longevity, Aging, R&D, funding – Learning with Lowell – 171 Read More »
Lisa Fabiny-Kiser CEO of SENS an aging / longevity research foundation to discuss SENS, their research projects, and more. Lisa links https://www.sens.org/about-us/team/ https://www.linkedin.com/in/lisa-fabiny-kiser-11793633/ PODCAST INFO: The Learning With Lowell show is a series for the everyday mammal. In this show we’ll learn about leadership, science, and people building their change into the world. The goal … Revolutionizing Longevity Research with SENS CEO Lisa Fabiny-Kiser-Learning with Lowell 168 Read More »
Dive into the research that Robin and his team have done in-house and their secret sauce, as well as exploring the current state of research on senescent cell elimination and its potential impact on healthspan and lifespan. Robin will also share his thoughts on the development pipeline for Deciduous Therapeutics’ immune mediated senolysis drugs, and … Senolytic Drugs & the Fight Against Aging with Robin Mansukhani | 159 | Learning With Lowell Read More »
CoFounder and formerHead Of Research at Turn Biotechnologies. Now working on his own thing. Passionate about developing unique and groundbreaking solutions to combat aging and degenerative disease. We dig into the mindset of innovation in this episode of the learning with lowell show. Jay links info@wethink64.com https://www.linkedin.com/in/jay-sarkar-979033211/ https://www.turn.bio/ PODCAST INFO: The Learning With Lowell show … Uncovering the Longevity Secret to Principle Innovation with Jay Sarkar | 158 | Learning with Lowell Read More »
Christin Glorioso MD, Phd, & founder of NeuroAge Therapeutics and Longevity Global. Today we are digging into the drama of supplements and specifically metformin & Nir Barzilai, research into Alzheimer’s, Aubrey De Grey concerns, David Sinclair Yamanaka factor mouse studies explained, Bryan Johnson 2 million a year longevity blueprint, brain age, books, and more. Also, … Brain Longevity, Supplement concerns, & Alzheimers Drama w/Dr. Christin Glorioso CEO of NeuroAge 156 Read More »
Kevin Perrott’s thesis on aging and its impact on the organization Open Cures. The episode also delves into the use of multi-omic data and the importance of biobank donations and giving blood. The conversation touches on the potential for colleges and students to be a focus for Open Cures and highlights bottlenecks that the organization … Kevin Perrott: Longevity, Aubrey De Grey, Michael Levin, OpenCures, Multi Omic Data, AI, ML – 152 Read More »
Aubrey De Grey discusses the progress and potential of therapies related to his ideas on anti-aging medicine, including the four therapies that will be tested in a mouse rejuvenation trial. He also shares his thoughts on partnering with organizations and individuals in the field, integrating AI into his work, and the importance of structure in … Aubrey De Grey:longevity escape velocity, longevity, mouse rejuvenation, Altos Labs, Yamanaka factor #149 Read More »
Longevity technologist, entrepreneur, outdoor adventurer. Wants to help build a utopian future where nobody gets sick and we can take ski vacations on Mars.
Everything you wanted to know about longevity, cholesterol, aging, and the brain and heart connection, but were afraid to ask.
We learn about DNA methylation, biomarkers, how bio/aging clocks are developed, the importance of them, the future of the longevity space, axolotl genome nerdiness, resource recommendations, and much more. Let’s stay curious, learn about Dr. Va-run and his passion in longevity and aging spaces.
“Dr. Moody is a process-oriented drug developer and executive who has specialized in the study of aging and aging mechanisms for over a decade. Since 2013, Dr. Moody has successfully built Ichor Therapeutics from a living room start-up into a premier, vertically integrated research organization focused on drug discovery and development for pathways of aging. … Longevity, Senescence, & Building a Therapeutic startup with Dr. Moody CEO Ichor Therapeutics Read More »
The next part in a series I've been doing on anti-aging researchers and research. The George Church and Nichola Conlon episodes already up. In this episode focuses on Mitochondria - we get into hurtles and problems with Mitochondria, next generation doping with Mitochondria , Leigh Syndrome (Mitochondria disease), and more in under 30 minutes.
E-vaccine, catabodies, healthy ageing,and age-associated diseases discussed with Stephanie and Sudhir founders of Covalent Bioscience.
PhD scientist turned startup founder that aims at taking the latest in scientific research to affect change in signs and processes of aging!